Anifrolumab treatment is linked to improved disease activity and reduced steroid use and has an acceptable safety profile in routine care of patients with systemic lupus erythematosus.

Objectives Pulmonary diseases (PDs) in SLE are thought to be common and of clinical importance but can be difficult to ...

Systemic lupus erythematosus (SLE) is characterized by autoantibody production, with anti-dsDNA antibodies (anti-dsDNA) being a key indicator for SLE diagnosis and disease monitoring. A new study ...

Objective The aim of this study was to assess the epidemiological and clinical characteristics of herpes zoster (HZ) and to ...

For the patient who presents with a new diagnosis of SLE, or for the one who has a flare in previously established disease, the immediate need is to achieve control of the inflammatory process. In ...